Logo image of UEPS

NET 1 UEPS TECHNOLOGIES INC (UEPS) Stock Fundamental Analysis

NASDAQ:UEPS - Nasdaq - US64107N2062 - Common Stock

4.58  -0.14 (-2.97%)

Fundamental Rating

3

Overall UEPS gets a fundamental rating of 3 out of 10. We evaluated UEPS against 82 industry peers in the IT Services industry. The financial health of UEPS is average, but there are quite some concerns on its profitability. While showing a medium growth rate, UEPS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year UEPS has reported negative net income.
UEPS Yearly Net Income VS EBIT VS OCF VS FCFUEPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M -100M -200M -300M

1.2 Ratios

Industry RankSector Rank
ROA -9.24%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UEPS Yearly ROA, ROE, ROICUEPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -20 -40 -60 -80

1.3 Margins

Industry RankSector Rank
OM -27.72%
PM (TTM) -23.6%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UEPS Yearly Profit, Operating, Gross MarginsUEPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 50 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for UEPS has been reduced compared to 1 year ago.
The debt/assets ratio for UEPS is higher compared to a year ago.
UEPS Yearly Shares OutstandingUEPS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
UEPS Yearly Total Debt VS Total AssetsUEPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B

2.2 Solvency

UEPS has an Altman-Z score of 2.72. This is not the best score and indicates that UEPS is in the grey zone with still only limited risk for bankruptcy at the moment.
UEPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.72
ROIC/WACCN/A
WACCN/A
UEPS Yearly LT Debt VS Equity VS FCFUEPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M 400M 600M

2.3 Liquidity

UEPS has a Current Ratio of 3.80. This indicates that UEPS is financially healthy and has no problem in meeting its short term obligations.
UEPS has a Quick Ratio of 3.53. This indicates that UEPS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.8
Quick Ratio 3.53
UEPS Yearly Current Assets VS Current LiabilitesUEPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

5

3. Growth

3.1 Past

UEPS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.25%, which is quite impressive.
The Revenue has grown by 38.99% in the past year. This is a very strong growth!
UEPS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -26.03% yearly.
EPS 1Y (TTM)49.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
Revenue 1Y (TTM)38.99%
Revenue growth 3Y-34.22%
Revenue growth 5Y-26.03%
Sales Q2Q%22.22%

3.2 Future

Based on estimates for the next years, UEPS will show a very strong growth in Earnings Per Share. The EPS will grow by 29.73% on average per year.
The Revenue is expected to grow by 39.77% on average over the next years. This is a very strong growth
EPS Next Y-33.38%
EPS Next 2Y76.77%
EPS Next 3Y43.55%
EPS Next 5Y29.73%
Revenue Next Year21.86%
Revenue Next 2Y39.81%
Revenue Next 3Y39.32%
Revenue Next 5Y39.77%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
UEPS Yearly Revenue VS EstimatesUEPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
UEPS Yearly EPS VS EstimatesUEPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 -1 2 -2 -3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UEPS. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 10.44 indicates a reasonable valuation of UEPS.
UEPS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 10.44
UEPS Price Earnings VS Forward Price EarningsUEPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2
UEPS Per share dataUEPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

UEPS's earnings are expected to grow with 43.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y76.77%
EPS Next 3Y43.55%

More info and screens

0

5. Dividend

5.1 Amount

UEPS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NET 1 UEPS TECHNOLOGIES INC

NASDAQ:UEPS (5/24/2022, 8:08:46 PM)

4.58

-0.14 (-2.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-10 2022-05-10/amc
Earnings (Next)N/A N/A
Inst Owners28.47%
Inst Owner Change2.97%
Ins Owners2.05%
Ins Owner Change0%
Market Cap271.04M
Analysts82.86
Price Target8.16 (78.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.44
P/S 1.6
P/FCF N/A
P/OCF N/A
P/B 1.07
P/tB N/A
EV/EBITDA -2
EPS(TTM)-0.47
EYN/A
EPS(NY)0.44
Fwd EY9.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.87
BVpS4.27
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.24%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -27.72%
PM (TTM) -23.6%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.8
Quick Ratio 3.53
Altman-Z 2.72
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.45%
EPS Next Y-33.38%
EPS Next 2Y76.77%
EPS Next 3Y43.55%
EPS Next 5Y29.73%
Revenue 1Y (TTM)38.99%
Revenue growth 3Y-34.22%
Revenue growth 5Y-26.03%
Sales Q2Q%22.22%
Revenue Next Year21.86%
Revenue Next 2Y39.81%
Revenue Next 3Y39.32%
Revenue Next 5Y39.77%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A